Abstract:This study investigated the role of the anterior cingulate cortex–lateral hypothalamus area (ACC–LHA) GABAergic neural pathway in modulating anxiety‐like behaviors, intestinal functions, and visceral hypersensitivity in mice, as well as its underlying mechanisms. Chemogenetic activation of the ACC–LHA GABAergic neurons induced anxiety‐like behaviors, diarrhea symptoms, and visceral hypersensitivity in normal mice, which was effectively reversed by GABAAR antagonist Bicuculline. Chemogenetic inhibition of the ACC–LHA GABAergic neurons relieved anxiety‐like behaviors, intestinal dysfunctions, and visceral hypersensitivity in mice model of irritable bowel syndrome (IBS), thus providing a potential treatment strategy for IBS‐like symptoms. Irritable bowel syndrome (IBS), which is characterized by chronic abdominal pain, has a high global prevalence. The anterior cingulate cortex (ACC), which is a pivotal region involved in pain processing, should be further investigated regarding its role in the regulation of visceral sensitivity and mental disorders. A C57BL/6J mouse model for IBS was established using chronic acute combining stress (CACS). IBS‐like symptoms were assessed using behavioral tests, intestinal motility measurements, and abdominal withdrawal reflex scores. Fluoro‐Gold retrograde tracing and immunohistochemistry techniques were employed to investigate the projection of ACC gamma‐aminobutyric acid‐producing (GABAergic) neurons to the lateral hypothalamus area (LHA). Chemogenetic approaches enabled the selective activation or inhibition of the ACC–LHA GABAergic pathway. Enzyme‐linked immunosorbent assay (ELISA) and western blot analyses were conducted to determine the expression of histamine, 5‐hydroxytryptamine (5‐HT), and transient receptor potential vanilloid 4 (TRPV4). Our findings suggest that CACS induced IBS‐like symptoms in mice. The GABA type A receptors (GABAAR) within LHA played a regulatory role in modulating IBS‐like symptoms. The chemogenetic activation of ACC–LHA GABAergic neurons elicited anxiety‐like behaviors, intestinal dysfunction, and visceral hypersensitivity in normal mice; however, these effects were effectively reversed by the administration of the GABAAR antagonist Bicuculline. Conversely, the chemogenetic inhibition of ACC–LHA GABAergic neurons alleviated anxiety‐like behaviors, intestinal dysfunction, and visceral hypersensitivity in the mouse model for IBS. These results highlight the crucial involvement of the ACC–LHA GABAergic pathway in modulating anxiety‐like behaviors, intestinal motility alterations, and visceral hypersensitivity, suggesting a potential therapeutic strategy for alleviating IBS‐like symptoms.

[Genetic aspects of the Stroop test].

Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice

Aggregation and Self-Assembly of Hydrophobins from Trichoderma Reesei: Low-Resolution Structural Models

Pasteurized akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice

MLCK-mediated Intestinal Permeability Promotes Immune Activation and Visceral Hypersensitivity in PI-IBS Mice

A13 MICROBIOTA FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) INDUCE ALTERED BEHAVIOUR AND VISCERAL HYPERSENSITIVITY IN MICROBIOTA-HUMANIZED MICE

Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats

Involvement Of Corticotropon-Relesing Factor And Receptors In Immune Cells In Irritable Bowel Syndrome

A technique for maintaining the patency of chest catheters following open-heart surgery.

Screening of probiotic strains to improve visceral hypersensitivity in irritable bowel syndrome by using in vitro and in vivo approaches

Transplantation of Fecal Microbiota from Patients with Irritable Bowel Syndrome Alters Gut Function and Behavior in Recipient Mice

The GABAergic pathway from anterior cingulate cortex to lateral hypothalamus area regulates irritable bowel syndrome in mice and its underlying mechanism

Saccharomyces Boulardiicncm I-745 Modulates The Microbiota-Gut-Brain Axis In A Humanized Mouse Model Of Irritable Bowel Syndrome

Microbiome and Its Role in Irritable Bowel Syndrome

Changes in signalling from faecal neuroactive metabolites following dietary modulation of IBS pain

Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome

The design and implementation of MST radar at Wuhan, China

Transcriptomic and Metabolomic Correlates of Increased Colonic Permeability in Postinfection Irritable Bowel Syndrome

Potential neuro-immune therapeutic targets in irritable bowel syndrome

ZO-1 and IL-1RAP Phosphorylation: Potential Role in Mediated Brain-Gut Axis Dysregulation in Irritable Bowel Syndrome-like Stressed Mice

Alteration of Gut Microbiome Induced by Berberine Improves Visceral Hypersensitivity Via Inhibiting Activation of Microglia